Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Frontiers in Pharmacology
|
March 29, 2021
Neurodegenerative Disease and the NLRP3 Inflammasome
Jonathan A Holbrook, Heledd H Jarosz-Griffiths, Emily Caseley, et al.
The Journal of Allergy and Clinical Immunology
|
February 24, 2023
Prevalence of CFTR variants in primary immunodeficiency patients with bronchiectasis is an important modifying cofactor
Dylan Lawless, Hana Lango Allen, James E D Thaventhiran, et al.
Elife
|
September 19, 2019
ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
Thomas Scambler, Heledd H Jarosz-Griffiths, Samuel Lara-Reyna, et al.
International Journal of Medical Informatics
|
May 22, 2018
The impact of three discharge coding methods on the accuracy of diagnostic coding and hospital reimbursement for inpatient medical care
Rosy Tsopra, Daniel Peckham, Paul Beirne, et al.
BMJ Open Respiratory Research
|
May 3, 2024
Considerations for the use of inhaled antibiotics for <i>Pseudomonas aeruginosa</i> in people with cystic fibrosis receiving CFTR modulator therapy
Pierre-Régis Burgel, Manfred Ballmann, Pavel Drevinek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 26, 2017
Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients
Xiaoli Meng, Zaid Al-Attar, Fiazia S Yaseen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 17, 2022
The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study
Rebecca J Birch, Daniel Peckham, Henry M Wood, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 11, 2018
Correction: Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients
Xiaoli Meng, Zaid Al-Attar, Fiazia S Yaseen, et al.
Chemical Research in Toxicology
|
September 22, 2022
Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients
Adriana Ariza, Kanoot Jaruthamsophon, Xiaoli Meng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 29, 2012
Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis
Sabah El-Ghaiesh, Manal M Monshi, Paul Whitaker, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Frontiers in Pharmacology
|
March 29, 2021
Neurodegenerative Disease and the NLRP3 Inflammasome
Jonathan A Holbrook, Heledd H Jarosz-Griffiths, Emily Caseley, et al.
The Journal of Allergy and Clinical Immunology
|
February 24, 2023
Prevalence of CFTR variants in primary immunodeficiency patients with bronchiectasis is an important modifying cofactor
Dylan Lawless, Hana Lango Allen, James E D Thaventhiran, et al.
Elife
|
September 19, 2019
ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
Thomas Scambler, Heledd H Jarosz-Griffiths, Samuel Lara-Reyna, et al.
International Journal of Medical Informatics
|
May 22, 2018
The impact of three discharge coding methods on the accuracy of diagnostic coding and hospital reimbursement for inpatient medical care
Rosy Tsopra, Daniel Peckham, Paul Beirne, et al.
BMJ Open Respiratory Research
|
May 3, 2024
Considerations for the use of inhaled antibiotics for <i>Pseudomonas aeruginosa</i> in people with cystic fibrosis receiving CFTR modulator therapy
Pierre-Régis Burgel, Manfred Ballmann, Pavel Drevinek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 26, 2017
Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients
Xiaoli Meng, Zaid Al-Attar, Fiazia S Yaseen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 17, 2022
The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study
Rebecca J Birch, Daniel Peckham, Henry M Wood, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 11, 2018
Correction: Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients
Xiaoli Meng, Zaid Al-Attar, Fiazia S Yaseen, et al.
Chemical Research in Toxicology
|
September 22, 2022
Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients
Adriana Ariza, Kanoot Jaruthamsophon, Xiaoli Meng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 29, 2012
Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis
Sabah El-Ghaiesh, Manal M Monshi, Paul Whitaker, et al.
Page
of 9